大洋洲 · 综合新闻 · The Australian
Orthocell partner receives US FDA clearance for marine-derived bone graft
Orthocell’s strategic partner Marine Biomedical has received US Food and Drug Administration (FDA) 510(k) clearance for PearlBone, a next-generation bone substitute developed…
在 The Australian 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.theaustralian.com.au)
